Skip to main content
SpringerLink
Log in

Current Trends in Antimicrobial Resistance of Escherichia coli

  • Chapter
  • First Online:
Escherichia coli, a Versatile Pathogen

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 416))

Abstract

Escherichia coli is the most common Gram-negative bacterial pathogen, presenting both a clinical and an epidemiological challenge. In the last decade, several successful multidrug-resistant high-risk strains, such as strain E. coli ST131 have evolved, mainly due to the growing selective pressure of antimicrobial use. These strains present enhanced fitness and pathogenicity, effective transmission and colonization abilities, global distribution due to efficient dissemination, and resistance to various antimicrobial resistances. Here, we describe the emerging trends and epidemiology of resistant E. coli, including carbapenemase-producing E. coli, E. coli ST131 and colistin resistant E. coli.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham EP, Chain E (1940) An enzyme from bacteria able to destroy penicillin. Nature 146:837

    CAS  Google Scholar 

  • Accogli M, Giani T, Monaco M, Giufre M, Garcia-Fernandez A, Conte V, D’Ancona F, Pantosti A, Rossolini GM, Cerquetti M (2014) Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases. Italy J Antimicrob Chemother 69:2293–2296

    CAS  PubMed  Google Scholar 

  • Adler A, Miller-Roll T, Assous MV, Geffen Y, Paikin S, Schwartz D, Weiner-Well Y, Hussein K, Cohen R, Carmeli Y (2015) A multicentre study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel. Clin Microbiol Infect 21:230–235

    CAS  PubMed  Google Scholar 

  • Ah YM, Kim AJ, Lee JY (2004) Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44:8–15

    Google Scholar 

  • Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8(4):260–271

    CAS  PubMed  Google Scholar 

  • Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I, Papadomichelakis E et al (2007) Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 59:786–790

    CAS  PubMed  Google Scholar 

  • Aschbacher R, Doumith M, Livermore DM, Larcher C, Woodford N (2008) Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano. Italy J Antimicrob Chemother 61:515–523

    CAS  PubMed  Google Scholar 

  • Aschbacher R, Pagani L, Doumith M, Pike R, Woodford N, Spoladore G et al (2011) Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008. Clin Microbiol Infect 17:181–189

    CAS  PubMed  Google Scholar 

  • Aschbacher R, Giani T, Corda D, Conte V, Arena F, Pasquetto V et al (2013) Carbapenemase-producing Enterobacteriaceae during 2011–12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting. Diagn Microbiol Infect Dis 77:354–356

    CAS  PubMed  Google Scholar 

  • Balakrishnan I, Awad-El-Kariem FM, Kumari P et al (2011) Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 66:2628–2631

    CAS  PubMed  Google Scholar 

  • Banerjee R, Johnson JR (2014) A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58:4997–5004

    PubMed  PubMed Central  Google Scholar 

  • Barguigua A, El Otmani F, El Yaagoubi FL, Talmi M, Zerouali K, Timinouni M (2013) First report of a Klebsiella pneumoniae strain coproducing NDM-1, VIM-1 and OXA-48 carbapenemases isolated in Morocco. APMIS 121:675–677

    PubMed  Google Scholar 

  • Ben Zakour NL, Alsheikh-Hussain AS, Ashcroft MM et al (2016) Sequential acquisition of virulence and fluoroquinolone resistance has shaped the evolution of Escherichia coli ST131. MBio 7(2):e00347–16

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bernasconi OJ, Kuenzli E, Pires J, Tinguely R, Carattoli A, Hatz C et al (2016) Travelers can import colistin-resistant Enterobacteriaceae including those possessing the plasmid-mediated mcr-1 gene. Antimicrob Agents Chemother 60(8):5080–5084

    CAS  PubMed  PubMed Central  Google Scholar 

  • Berthe T, Ratajczak M, Clermont O, Denamur E, Petit F (2013) Evidence for coexistence of distinct Escherichia coli populations in various aquatic environments and their survival in estuary water. Appl Environ Microbiol 79:4684–4693

    CAS  PubMed  PubMed Central  Google Scholar 

  • Beyrouthy R, Robin F, Cougnoux A, Dalmasso G, Darfeuille-Michaud A, Mallat H, Dabboussi F, Hamzé M, Bonnet R (2013) Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli. J Antimicrob Chemother 68:1558–1561

    CAS  PubMed  Google Scholar 

  • Beyrouthy R, Robin F, Delmas J, Gibold L, Dalmasso G, Dabboussi F, Hamzé M, Bonnet R (2014) IS1R-mediated plasticity of IncL/M plasmids leads to the insertion of bla OXA-48 into the Escherichia coli chromosome. Antimicrob Agents Chemother 58:3785–9790

    CAS  PubMed  PubMed Central  Google Scholar 

  • Biedenbach D, Bouchillon S, Hackel M, Hoban D, Kazmierczak K, Hawser S et al (2015) Dissemination of NDM metallo-beta-lactamase genes among clinical isolates of Enterobacteriaceae collected during the SMART global surveillance study from 2008 to 2012. Antimicrob Agents Chemother 59(2):826–830

    CAS  PubMed  PubMed Central  Google Scholar 

  • Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec JY, Rafignon G, Bruno P, Mora A, Lopez C et al (2014) Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J Antimicrob Chemother 69:1231–1237

    CAS  PubMed  Google Scholar 

  • Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12

    PubMed  Google Scholar 

  • Bush K (2015) A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. Int J Antimicrob Agents 46(5):483–493

    CAS  PubMed  Google Scholar 

  • Cai JC, Zhang R, Hu YY, Zhou HW, Chen GX (2014) Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother 58:1146–1152

    PubMed  PubMed Central  Google Scholar 

  • Cantón R, González-Alba JM, Galán JC (2012) CTX-M enzymes: origin and diffusion. Front Microbiol 3:110

    PubMed  PubMed Central  Google Scholar 

  • Carattoli A, Aschbacher R, March A, Larcher C, Livermore DM, Woodford N (2010) Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA. J Antimicrob Chemother 65:2070–2075

    CAS  PubMed  Google Scholar 

  • Carattoli A, Seiffert SN, Schwendener S, Perreten V, Endimiani A (2015) Differentiation of IncL and IncM plasmids associated with the spread of clinically relevant antimicrobial resistance. PLoS ONE 10:1–14

    Google Scholar 

  • Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE (2011a) Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob Agents Chemother 55(3):1274–1278

    CAS  PubMed  Google Scholar 

  • Castanheira M, Mendes RE, Woosley LN, Jones RN (2011b) Trends in carbapenemase producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007–09). J Antimicrob Chemother 66(6):1409–1411

    CAS  PubMed  Google Scholar 

  • Chen L, Todd R, Kiehlbauch J, Walters M, Kallen A (2017) Notes from the field: pan-resistant New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae—Washoe County, Nevada, 2016. MMWR Morb Mortal Wkly Rep 66:33

    PubMed  PubMed Central  Google Scholar 

  • Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, Livermore DM (2001) IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 45:710–714

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cornaglia G, Riccio ML, Mazzariol A, Lauretti L, Fontana R, Rossolini GM (1999) Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet 353(9156):899–900

    CAS  PubMed  Google Scholar 

  • Dale AP, Woodford N (2015) Extra-intestinal pathogenic Escherichia coli (ExPEC): disease, carriage and clones. J Infect 71:615–626

    PubMed  Google Scholar 

  • Dautzenberg MJ, Ossewaarde JM, de Kraker ME et al (2014) Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill 19:pii:20723

    Google Scholar 

  • de la Tabla VO, Ortega A, Buñuel F, Pérez-Vázquez M, Marcos B, Oteo J (2017) Detection of the high-risk clone ST131 of Escherichia coli carrying the colistin resistance gene mcr-1 and causing acute peritonitis. Int J Antimicrob Agents 49:115–116

    Google Scholar 

  • Delgado-Blas JF, Ovejero CM, Abadia-Patiño L et al (2016) Coexistence of mcr-1 and blaNDM-1 in Escherichia coli from Venezuela. Antimicrob Agents Chemother 60:6356–6358

    Google Scholar 

  • Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman R (2010) New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India 58:147–149

    PubMed  Google Scholar 

  • Dimou V, Dhanji H, Pike R, Livermore DM, Woodford N (2012) Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob Chemother 67:1660–1665

    CAS  PubMed  Google Scholar 

  • Du H, Chen L, Tang YW, Kreiswirth BN (2016) Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 16(3):287–288

    CAS  PubMed  Google Scholar 

  • Edelsberg J, Weycker D, Barron R et al (2014) Prevalence of antibiotic resistance in US hospitals. Diagn Microbiol Infect Dis 78:255–262

    CAS  PubMed  Google Scholar 

  • European Centre for Disease Prevention and Control (ECDC) (2008) Annual epidemiological report on communicable diseases in Europe 2008. Stockholm, Sweden. Available at: http://ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_2008.pdf. Accessed 25 Dec 2017

  • European Centre for Disease Prevention and Control (ECDC) (2015) Antimicrobial resistance surveillance in Europe 2014. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, Sweden: ECDC; 2015. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf. Accessed 14 Jan 2017

  • European Centre for Disease Prevention and Control/European Medicines Agency Joint Working Group (ECDC/EMEA) (2009) The bacterial challenge: time to react. Available at: www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed 25 Dec 2017

  • Ewers C, Göttig S, Bülte M, Fiedler S, Tietgen M, Leidner U et al (2016) Genome sequence of avian Escherichia coli strain IHIT25637, an extraintestinal pathogenic E. coli strain of ST131 encoding colistin resistance determinant MCR-1. Genome Announc 4:e00863–16

    PubMed  PubMed Central  Google Scholar 

  • Giakkoupi P, Xanthaki A, Kanelopoulo M et al (2003) VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41(8):3893–3896

    CAS  PubMed  PubMed Central  Google Scholar 

  • Giamarellou H (2016) Epidemiology of infections caused by polymyxin-resistant pathogens. Int J Antimicrob Agents 48(6):614–621

    CAS  PubMed  Google Scholar 

  • Giamarellou H, Galani L, Baziaka F, Karaiskos I (2013) Effectiveness of a double carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 57:2388–2390

    CAS  PubMed  PubMed Central  Google Scholar 

  • Giani T, Contem V, Di Pilato V, Aschbacher R, Weber C, Larcher C, Rossolini GM (2012) Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob Agents Chemother 56:2211–2213

    CAS  PubMed  PubMed Central  Google Scholar 

  • Glasner C, Albiger B, Buist G et al (2013) Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 18:pii: 20575

    Google Scholar 

  • Groisman EA (2001) The pleiotropic two-component regulatory system PhoP-PhoQ. J Bacteriol 183:1835–1842

    CAS  PubMed  PubMed Central  Google Scholar 

  • Haenni M, Poirel L, Kieffer N, Chatre P, Saras E, Metayer V et al (2016) Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis 16:281–282

    CAS  PubMed  Google Scholar 

  • Harris PN, Peleg AY, Iredell J et al (2015) Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials 16:24

    PubMed  PubMed Central  Google Scholar 

  • Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agerso Y et al (2015) Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 20(49):30085

    Google Scholar 

  • Hernandez M, Iglesias MR, Rodríguez-Lázaro D, Gallardo A, Quijada N, Miguela-Villoldo P, Campos MJ, Píriz S, López-Orozco G, de Frutos C, Sáez JL, Ugarte-Ruiz M, Domínguez L, Quesada A (2017) Co-occurrence of colistin-resistance genes mcr-1 and mcr-3 among multidrug-resistant Escherichia coli isolated from cattle, Spain, September 2015. Euro Surveill 22(31):pii: 30586

    Google Scholar 

  • Herzer PJ, Inouye S, Inouye M, Whittam TS (1990) Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 172(11):6175–6181

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ho PL, Cheung YY, Wang Y, Lo W, Yai E, Chow K et al (2016) Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong. Eur J Clin Microbiol Infect Dis 35:379–385

    CAS  PubMed  Google Scholar 

  • Hossain A, Ferraro MJ, Pino RM, Dew RB Jr, Moland ES, Lockhart TJ et al (2004) Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp. Antimicrob Agents Chemother 48(11):4438–4440

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ito H, Arakawa Y, Ohsuka S, Wacharotayankun R, Kato N, Ohta M (1995) Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Antimicrob Agents Chemother 39(4):824–829

    CAS  PubMed  PubMed Central  Google Scholar 

  • Iyobe S, Kusadokoro H, Ozaki J, Matsumura N, Minami S, Haruta S, Sawai T, O’Hara K (2000) Amino acid substitutions in a variant of IMP-1 metallo-beta-lactamase. Antimicrob Agents Chemother 44:2023–2027

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jin L, Wang R, Wang X, Wang Q, Zhang Y, Yin Y, Wang H (2018) Emergence of mcr- and carbapenemase genes in hospital sewage water in Beijing, China. J Antimicrob Chemother 73(1):84–87

    PubMed  Google Scholar 

  • Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M (2010) Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286–294

    PubMed  Google Scholar 

  • Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E (2014) Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J Clin Microbiol 52:1358–1365

    PubMed  PubMed Central  Google Scholar 

  • Johnson TJ, Hargreaves M, Shaw K, Snippes P, Lynfield R, Aziz M, Price LB (2015) Complete genome sequence of a carbapenem-resistant extraintestinal pathogenic Escherichia coli strain belonging to the sequence type 131 H30R subclade. Genome Announc 3(2). https://doi.org/10.1128/genomea.00272-15

  • Johnson TJ, Danzeisen JL, Youmans B et al (2016) Separate F-type plasmids have shaped the evolution of the H30 subclone of Escherichia coli sequence type 131. mSphere 1(4):e00121–16

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140

    CAS  PubMed  Google Scholar 

  • Karaiskos I, Giamarellou H (2014) Multidrug-resistant and extensively drug-resistant Gram-negative pathogens approaches. Expert Opin Pharmacother 15:1351–1370

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kazmierczak KM, Rabine S, Hackel M, McLaughlin RE, Biedenbach DJ, Bouchillon SK et al (2015) Multiyear, multinational survey of the incidence and global distribution of metallo-beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 60(2):1067–1078

    PubMed  Google Scholar 

  • Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y (2012) Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 55:224–231

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kim Y, Cunningham MA, Mire J, Tesar C, Sacchettini J, Joachimiak A (2013) NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J 27:1917–1927

    CAS  PubMed  PubMed Central  Google Scholar 

  • Klevens RM, Edwards JR, Richards CL et al (2007) Estimating healthcare-associated infections in U.S. hospitals. Public Health Rep 122:160–166

    PubMed  PubMed Central  Google Scholar 

  • Koh TH, Babini GS, Woodford N, Sng LH, Hall LM, Livermore DM (1999) Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353:2162

    CAS  PubMed  Google Scholar 

  • Kontopidou F, Plachouras D, Papadomichelakis E, Koukos G, Galani I, Poulakou G et al (2011) Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect 17:E9–E11

    CAS  PubMed  Google Scholar 

  • Kotsanas D, Wijesooriya WR, Korman TM, Gillespie EE, Wright L, Snook K, Williams N, Bell JM, Li HY, Stuart RL (2013) “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198:267–269

    PubMed  Google Scholar 

  • Ktari S, Arlet G, Mnif B et al (2006) Emergence of multidrugresistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian University Hospital. Antimicrob Agents Chemother 50:4198–4201

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kumarasamy KK, Toleman MA, Walsh TR et al (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10(9):597–602

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kuo SC, Huang WC, Wang HY, Shiau YR, Cheng MF, Lauderdale TL (2016) Colistin resistance gene mcr-1 in Escherichia coli isolates from humans and retail meats, Taiwan. J Antimicrob Chemother 71:2327–2329

    CAS  PubMed  Google Scholar 

  • Lartigue MF, Poirel L, Nordmann P (2004) First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob Agents Chemother 48:4929–4930

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lascols C, Hackel M, Marshall SH et al (2011) Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 66(9):1992–1997

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R (1999) Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43:1584–1590

    CAS  PubMed  PubMed Central  Google Scholar 

  • Laxminarayan R, Duse A, Wattal C et al (2013) Antibiotic resistance the need for global solutions. Lancet Infect Dis 13:1057–1098

    PubMed  Google Scholar 

  • Leangapichart T, Gautret P, Brouqui P, Memish Z, Raoult D, Rolain JM (2016) Acquisition of mcr-1 plasmid-mediated colistin resistance in Escherichia coli and Klebsiella pneumoniae during Hajj 2013 and 2014. Antimicrob Agents Chemother 60:6998–6999

    CAS  PubMed  PubMed Central  Google Scholar 

  • Lentz SA, de Lima-Morales D, Cuppertino VM, Nunes L, da Motta AS, Zavascki AP et al (2016) Escherichia coli harbouring mcr-1 gene isolated from poultry not exposed to polymyxins in Brazil. Euro Surveill 21

    Google Scholar 

  • Leverstein-Van Hall MA, Stuart JC, Voets GM, Versteeg D, Tersmette T, Fluit AC (2010) Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 10(12):830–831

    PubMed  Google Scholar 

  • Levin AS, Barone AA, Penחo J, Santos MV, Marinho IS, Arruda EA et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrugresistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011

    CAS  PubMed  Google Scholar 

  • Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161–168

    PubMed  Google Scholar 

  • March A, Aschbacher R, Pagani E, Sleghel F, Soelva G, Hopkins KL et al (2014) Changes in colonization of residents and staff of a long-term care facility and an adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year period. Scand J Infect Dis 46:114–122

    PubMed  Google Scholar 

  • Mathers AJ, Peirano G, Pitout JD (2015) Escherichia coli ST131: the quintessential example of an international multiresistant high-risk clone. Adv Appl Microbiol 90:109–154

    PubMed  Google Scholar 

  • Matsumura Y, Johnson JR, Yamamoto M et al (2015) CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic. J Antimicrob Chemother 70(6):1639–1649

    CAS  PubMed  Google Scholar 

  • Matsumura Y, Pitout JD, Gomi R et al (2016) Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene. Emerging Infect Dis 22(11):1900–1907

    CAS  PubMed  PubMed Central  Google Scholar 

  • McGann P, Snesrud E, Maybank R, Corey B, Ong AC, Clifford R et al (2016) Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1in the United States. Antimicrob Agents Chemother 60:4420–4421

    CAS  PubMed  PubMed Central  Google Scholar 

  • Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T et al (2010) Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 54:4971–4977

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mokady D, Gophna U, Ron EZ (2005) Virulence factors of septicemic Escherichia coli strains. Int J Med Microbiol 295:455–462

    CAS  PubMed  Google Scholar 

  • Morris D, Boyle F, Ludden C, Condon I, Hale J, O’Connell N, Power L, Boo TW, Dhanji H, Lavallee C, Woodford N, Cormican M (2011) Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob Agents Chemother 55:4935–4936

    CAS  PubMed  PubMed Central  Google Scholar 

  • Morris D, McGarry E, Cotter M, Passet V, Lynch M, Ludden C, Hannan MM, Brisse S, Cormican M (2012) Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 56:4030–4031

    CAS  PubMed  PubMed Central  Google Scholar 

  • Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P (2008) Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob Agents Chemother 52:1257–1263

    CAS  PubMed  PubMed Central  Google Scholar 

  • Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P (2011) When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob Agents Chemother 55:4933–4934

    CAS  PubMed  PubMed Central  Google Scholar 

  • Naseer U, Sundsfjord A (2011) The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb Drug Resist 17:83–97

    CAS  PubMed  Google Scholar 

  • Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11:142–201

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61:273–281

    CAS  PubMed  Google Scholar 

  • Nicolas-Chanoine MH, Bertrand X, Madec JY (2014) Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543–574

    CAS  PubMed  PubMed Central  Google Scholar 

  • Niranjan V, Malini A (2014) Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res 139:945–948

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nordmann P, Poirel L (2014) The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20:821–830

    CAS  Google Scholar 

  • Nordmann P, Poirel L (2016) Plasmid-mediated colistin resistance: an additional antibiotic resistance menace. Clin Microbiol Infect 22:398–400

    CAS  PubMed  Google Scholar 

  • Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9(4):228–236

    CAS  PubMed  Google Scholar 

  • Nordmann P, Naas T, Poirel L (2011a) Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nordmann P, Poirel L, Walsh TR, Livermore DM (2011b) The emerging NDM carbapenemases. Trends Microbiol 19(12):588–595

    CAS  PubMed  Google Scholar 

  • Nordmann P, Gniadkowski M, Giske CG et al (2012) Identificationand screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18:432–438

    CAS  PubMed  Google Scholar 

  • Ohno Y, Nakamura A, Hashimoto E, Matsutani H, Abe N, Fukuda S, Hisashi K, Komatsu M, Nakamura F (2017) Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010–2013. J Infect Chemother 23:224–229

    PubMed  Google Scholar 

  • Ortega A, Saez D, Bautista V et al (2016) Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48. J Antimicrob Chemother 71(8):2131–2138

    PubMed  Google Scholar 

  • Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N (1994) Molecular characterization of an enterobacterial metallo-b-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71–78

    CAS  PubMed  PubMed Central  Google Scholar 

  • Oteo J, Ortega A, Bartolomé R et al (2015) Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother 59:3406–3412

    CAS  PubMed  PubMed Central  Google Scholar 

  • Paul M, Carmeli Y, Durante-Mangoni E et al (2014) Combination therapy for carbapenem-resistant Gram-negative bacteria. J Antimicrob Chemother 69:2305–2309

    CAS  PubMed  Google Scholar 

  • Peirano G, Pitout JD (2010) Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 35(4):316–332

    CAS  PubMed  Google Scholar 

  • Peirano G, Schreckenberger PC, Pitout JDD (2011) Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. Antimicrob Agents Chemother 55:2986–2988

    CAS  PubMed  PubMed Central  Google Scholar 

  • Peirano G, Bradford PA, Kazmierczak KM, Badal RE, Hackel M, Hoban DJ, Pitout JD (2014) Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis 20:1928–1931

    CAS  PubMed  PubMed Central  Google Scholar 

  • Peleg AY, Franklin C, Bell JM, Spelman DW (2005) Dissemination of the metallo-β-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis 41:1549–1556

    CAS  PubMed  Google Scholar 

  • Pelletier MR, Casella LG, Jones JW, Adams MD, Zurawski DV, Hazlett KR et al (2013) Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob Agents Chemother 57:4831–4840

    CAS  PubMed  PubMed Central  Google Scholar 

  • Perry JD, Naqvi SH, Mirza IA et al (2011) Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 66(10):2288–2294

    CAS  PubMed  Google Scholar 

  • Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E et al (2014) Global dissemination of a multidrugresistant Escherichia coli clone. Proc Natl Acad Sci USA 111:5694–5699

    CAS  PubMed  Google Scholar 

  • Pitout JD (2012a) Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther 10:1165–1176

    CAS  PubMed  Google Scholar 

  • Pitout JD (2012b) Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 3:9

    PubMed  PubMed Central  Google Scholar 

  • Pitout JD, Laupland KB (2008) Extendedspectrum beta-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dis 8(3):159–166

    CAS  PubMed  Google Scholar 

  • Pitout JD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59(10):5873–5884

    CAS  PubMed  PubMed Central  Google Scholar 

  • Poirel L, Héritier C, Tolun V, Nordmann P (2004) Emergence of oxacillinase mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22

    CAS  PubMed  PubMed Central  Google Scholar 

  • Poirel L, Pitout JD, Nordmann P (2007) Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2(5):501–512

    CAS  PubMed  Google Scholar 

  • Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P (2010) Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 10:832

    PubMed  Google Scholar 

  • Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P (2011) OXA-163, an OXA-48-related class D betalactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55:2546–2551

    CAS  PubMed  PubMed Central  Google Scholar 

  • Poirel L, Potron A, Nordmann P (2012a) OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:1597–1606

    CAS  PubMed  Google Scholar 

  • Poirel L, Bonnin RA, Nordmann P (2012b) Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 56:559–562

    CAS  PubMed  PubMed Central  Google Scholar 

  • Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P (2013) Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Intern J Antimicrob Agents 41:90–91

    CAS  Google Scholar 

  • Price LB, Johnson JR, Aziz M, Clabots C, Johnston B et al (2013) The epidemic of extended-spectrum-β-lactamaseproducing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-RX. MBio 4:e00377–00313

    PubMed  PubMed Central  Google Scholar 

  • Riccio ML, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, Amicosante G, Rossolini GM (2000) Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 44:1229–1235

    CAS  PubMed  PubMed Central  Google Scholar 

  • Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R (2010) Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob Agents Chemother 54:466–470

    CAS  PubMed  Google Scholar 

  • Rodríguez I, Thomas K, Van Essen A, Schink AK, Day M, Chattaway M, Wu G, Mevius D, Helmuth R, Guerra B, SAFEFOODERA-ESBL Consortium (2014) Consortium S-E: chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK. Int J Antimicrob Agents 43:553–557

    Google Scholar 

  • Roer L, Hansen F, Stegger M, Sönksen UW, Hasman H, Hammerum AM (2017) Novel mcr-3 variant, encoding mobile colistin resistance, in an ST131 Escherichia coli isolate from bloodstream infection, Denmark, 2014. Euro Surveill 22(31):30584

    PubMed Central  Google Scholar 

  • Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1–14

    CAS  PubMed  Google Scholar 

  • Ron EZ (2006) Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr Opin Microbiol 9:28–32

    CAS  PubMed  Google Scholar 

  • Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect Inst Pasteur 5:449–456

    Google Scholar 

  • Schembri MA, Zakour NL, Phan MD, Forde BM, Stanton-Cook M, Beatson SA (2015) Molecular characterization of the multidrug resistant Escherichia coli ST131 clone. Pathogens 4:422–430

    CAS  PubMed  PubMed Central  Google Scholar 

  • Seema K, Ranjan Sen M, Upadhyay S, Bhattacharjee A (2011) Dissemination of the New Delhi metallo-b-lactamase-1 (NDM-1) among Enterobacteriaceae in a tertiary referral hospital in north India. J Antimicrob Chemother 66(7):1646–1647

    CAS  PubMed  Google Scholar 

  • Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, Kato N, Ohta M (1996a) Multifocal outbreaks of metallo-beta-lactamase producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams including carbapenems. Antimicrob Agents Chemother 40:349–353

    CAS  PubMed  PubMed Central  Google Scholar 

  • Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, Shimokata K, Kato N, Ohta M (1996b) PCR detection of metallo-blactamase gene (blaIMP) in gram-negative rods resistant to broad spectrum b-lactams. J Clin Microbiol 34:2909–2913

    CAS  PubMed  PubMed Central  Google Scholar 

  • Shen Z, Wang Y, Shen Y, Shen J, Wu C (2016) Early emergence of mcr-1 in Escherichia coli from food-producing animals. Lancet Infect Dis 16:293

    PubMed  Google Scholar 

  • Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S (2015) Clinical epidemiology and molecular analysis of extended-spectrum B-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648. Antimicrob Agents Chemother 59:3424–3432

    CAS  PubMed  PubMed Central  Google Scholar 

  • Shlaes DM, Sahm D, Opiela C, Spellberg B (2013) The FDA reboot of antibiotic development. Antimicrob Agents Chemother 57:4605–4607

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sidjabat HE, Heney C, George NM, Nimmo GR, Paterson DL (2014) Interspecies transfer of blaIMP-4 in a patient with prolonged colonization by IMP-4-producing Enterobacteriaceae. J Clin Microbiol 52:3816–3818

    PubMed  PubMed Central  Google Scholar 

  • Sidjabat HE, Townell N, Nimmo GR, George NM, Robson J, Vohra R et al (2015a) Dominance of IMP-4-producing Enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia. Antimicrob Agents Chemother 59(7):4059–4066

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sidjabat HE, Robson J, Paterson DL (2015b) Draft genome sequences of two IMP-4-producing Escherichia coli sequence type 131 isolates in Australia. Genome Announc 3:e00983–00915

    PubMed  PubMed Central  Google Scholar 

  • Skov RL, Monnet DL (2016) Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill 21. https://doi.org/10.2807/1560-7917

  • Sonnevend A, Ghazawi A, Alqahtani M, Shibl A, Jamal W, Hashmey R et al (2016) Plasmid-mediated colistin resistance in Escherichia coli from the Arabian Peninsula. Int J Infect Dis 50:85–90

    CAS  PubMed  Google Scholar 

  • Stoesser N, Sheppard AE, Pankhurst L et al (2016) Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. MBio 7(2):e02162

    CAS  PubMed  PubMed Central  Google Scholar 

  • Trent MS (2004) Biosynthesis, transport, and modification of lipid A. Biochem Cell Biol 82:71–86

    CAS  PubMed  Google Scholar 

  • Tumbarello M, Viale P, Viscoli C et al (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55:943–950

    CAS  PubMed  Google Scholar 

  • Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL (2012) Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:682–707

    CAS  PubMed  PubMed Central  Google Scholar 

  • US CDC (2016a) Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs). Tracking CRE infections; 2016. Available at: https://www.cdc.gov/hai/organisms/cre/trackingcre.html. Accessed 25 Dec 2017

  • US CDC (2016b) Centers for Disease Control and Prevention. One Health. CDC; Available at: https://www.cdc.gov/onehealth/. Accessed 17 Jan 2018

  • Vatopoulos A (2008) High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece—a review of the current evidence. Euro Surveill 13(4):PMid:18445397

    Google Scholar 

  • Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. P T 40(4):277–283

    PubMed  PubMed Central  Google Scholar 

  • Walsh TR, Weeks J, Livermore DM, Toleman MA (2011) Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11:355–362

    PubMed  Google Scholar 

  • Wang JT, Wu UI, Lauderdale TL, Chen MC, Li SY, Hsu LY, Chang SC (2015) Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan. PLoS ONE 10:e0121668

    PubMed  PubMed Central  Google Scholar 

  • Wang J, Yuan M, Chen H, Chen X, Jia Y, Zhu X, Bai L, Bai X, Fanning S, Lu J, Li J (2017a) First report of Klebsiella oxytoca strain simultaneously producing NDM-1, IMP-4, and KPC-2 carbapenemases. Antimicrob Agents Chemother 61:e00877–17

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Tian GB, Zhang R, Shen Y, Tyrrell JM, Huang X et al (2017b) Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study. Lancet Infect Dis 17:390–399

    CAS  PubMed  Google Scholar 

  • WHO, World Health Organization (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, February 2017. Available at: http://www.who.int/medicines/publications/WHO-PPLShort_Summary_25Feb-ET_NM_WHO.pdf. Accessed 25 Dec 2017

  • World Health Organization (2014) Antimicrobial resistance: global report on surveillance 2014. World Health Organization 2014:257. Available at: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1. Accessed 25 Dec 2017

  • Wright H, Bonomo RA, Paterson DL (2017) New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn? Clin Microbiol Infect 23:704–712

    CAS  Google Scholar 

  • Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H et al (2016) Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill: bulletin Europeen sur les maladies transmissibles = Eur Commun Dis Bull 21(27):S1

    Google Scholar 

  • Yaffee AQ, Roser L, Daniels K, Humbaugh K, Brawley R, Thoroughman D et al (2016) Notes from the field: verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Enterobacteriaceae in a neonatal and adult intensive care unit-Kentucky, 2015. MMWR Morb Mortal Wkly Rep 65(7):190

    PubMed  Google Scholar 

  • Yan JJ, Tsai LH, Wu JJ (2012) Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan. Int J Antimicrob Agents 40:281–282

    CAS  PubMed  Google Scholar 

  • Yang RS, Feng Y, Lv XY, Duan JH, Chen J, Fang LX et al (2016) Emergence of NDM-5 and MCR-1-producing Escherichia coli clones ST648 and ST156 from a single Muscovy duck (Cairina moschata). Antimicrob Agents Chemother 60:6899–6902

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yao X, Doi Y, Zeng L, Lv L, Liu JH (2016) Carbapenem-resistant and colistin resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 16:288–289

    CAS  PubMed  Google Scholar 

  • Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD et al (2001) Novel carbapenem-hydrolyzing b-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yong D, Toleman MA, Giske CG et al (2009) Characterization of a new metallo-betalactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53(12):5046–5054

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zarkotou O, Pournaras S, Tselioti P et al (2011) Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 17:1798–1803

    CAS  PubMed  Google Scholar 

  • Zavascki AP, Bulitta JB, Landersdorfer CB (2013) Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert Rev Anti Infect Ther 11:1333–1353

    CAS  PubMed  Google Scholar 

  • Zhang F, Zhu D, Xie L, Guo X, Ni Y, Sun J (2015) Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China. Eur J Clin Microbiol Infect Dis 34(6):1263–1269

    CAS  PubMed  Google Scholar 

  • Zheng B, Zhang J, Ji J, Fang Y, Shen P, Ying C et al (2015) Emergence of Raoultella ornithinolytica coproducing IMP-4 and KPC-2 carbapenemases in China. Antimicrob Agents Chemother 59(11):7086–7089

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zheng B, Lv T, Xu H, Yu X, Chen Y, Li J, Huang C, Guo L, Zhang J, Jiang X, Xiao Y, Li L (2017) Discovery and characterization of an Escherichia coli ST206 strain producing NDM-5 and MCR-1 from a patient with acute diarrhea in China. Int J Antimicrob Agents. 14 Sep 2017. pii: S0924-8579(17)30345-X. https://doi.org/10.1016/j.ijantimicag.2017.09.005. [Epub ahead of print]

    CAS  PubMed  Google Scholar 

  • Zong Z (2013) Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain. Antimicrob Agents Chemother 57:597–600

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zowawi HM, Forde BM, Alfaresi M, Alzarouni A, Farahat Y, Chong TM et al (2015) Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae. Sci Rep 5:15082

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Microbiology Laboratory, Meir Medical Center, 44282, Kfar Saba, Israel

    Yossi Paitan

  2. Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, 39978, Tel Aviv, Israel

    Yossi Paitan

Authors
  1. Yossi Paitan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yossi Paitan .

Editor information

Editors and Affiliations

  1. Department of Life Sciences, Imperial College London, London, UK

    Gad Frankel

  2. Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

    Eliora Z Ron

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Paitan, Y. (2018). Current Trends in Antimicrobial Resistance of Escherichia coli. In: Frankel, G., Ron, E. (eds) Escherichia coli, a Versatile Pathogen. Current Topics in Microbiology and Immunology, vol 416. Springer, Cham. https://doi.org/10.1007/82_2018_110

Download citation

Publish with us

Policies and ethics

Search

Navigation